You are here

  • Home
  • Archive
  • Volume 9, Issue 3
  • Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19–IL2 cures poorly immunogenic tumors when combined with radiotherapy

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19–IL2 cures poorly immunogenic tumors when combined with radiotherapy

 

Online download statistics by month:

Online download statistics by month: March 2021 to August 2024

AbstractFullPdf
Mar 2021477477240
Apr 202126126195
May 202117517575
Jun 202116816861
Jul 202130330344
Aug 202119219253
Sep 202113613682
Oct 202113713766
Nov 202120020173
Dec 202119820085
Jan 202214315157
Feb 2022878826
Mar 202214815973
Apr 20229610240
May 202212213773
Jun 202213814549
Jul 202213013454
Aug 202210711051
Sep 202212913366
Oct 202215215581
Nov 202213113680
Dec 2022727235
Jan 202312713062
Feb 202318718784
Mar 202314314753
Apr 202317417794
May 20231083108851
Jun 202318819059
Jul 202314414545
Aug 202314715046
Sep 202316616759
Oct 202315916157
Nov 202313813852
Dec 202313113350
Jan 2024546042
Feb 202412512854
Mar 2024164171122
Apr 202415815963
May 202414815054
Jun 202410510639
Jul 202416416846
Aug 202412212260
Total752976492751